Beyond Tissue Stiffness and Bioadhesivity: Advanced Biomaterials to Model Tumor Microenvironments and Drug Resistance

Ankur Singh1, Ilana Brito2, Jan Lammerding3

  • 1Nancy E. and Peter C. Meinig School of Biomedical Engineering, Cornell University, Ithaca, NY, USA; Sibley School of Mechanical and Aerospace Engineering, Cornell University, Ithaca, NY, USA; Caryl and Israel Englander Institute for Precision Medicine, New York Presbyterian Hospital-Weill Cornell Medicine, New York, NY, USA.

Trends in Cancer
|April 3, 2018
PubMed

Insights

New preclinical models are crucial for understanding cancer development and chemoresistance. Advanced ex vivo models incorporating tissue signaling, nuclear mechanics, and the gut microbiome offer unprecedented opportunities for therapeutic design.

Area of Science:

  • Oncology
  • Cancer Research
  • Experimental Therapeutics

Background:

  • Chemotherapy and targeted therapies face significant challenges due to cancer resistance.
  • Ex vivo preclinical tissue models have advanced tumor biology but not fully addressed malignant transformation and chemoresistance.
  • Genomic sequencing and advanced ex vivo models offer new avenues for understanding cancer.

Purpose of the Study:

  • To highlight the limitations of current ex vivo models in addressing cancer resistance.
  • To propose a more comprehensive approach for developing next-generation ex vivo models.
  • To leverage new models for understanding tumorigenesis and overcoming therapeutic resistance.

Main Methods:

  • Discussion of limitations in current ex vivo models.
  • Identification of key biological and physical parameters for improved models.
  • Integration of genomic data with advanced tissue engineering.

Main Results:

  • Current ex vivo models do not adequately capture the complexity of cancer development and resistance.
  • A comprehensive milieu including tissue signaling, nuclear mechanics, immune response, and gut microbiome is essential.
  • Advanced ex vivo models can provide unprecedented opportunities for therapeutic design.

Conclusions:

  • Next-generation ex vivo models must incorporate a broader range of physiological and biological factors.
  • Improved models are critical for a deeper understanding of tumorigenesis and chemoresistance.
  • This approach will facilitate the design of more effective cancer therapies.

Related Concept Videos

The Tumor Microenvironment02:17

The Tumor Microenvironment

Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
7.9K
Tissue-Drug Binding: Localization of Drugs and its Significance01:24

Tissue-Drug Binding: Localization of Drugs and its Significance

Body tissues, comprising approximately 40% of the body weight, are crucial in drug distribution and localization. These tissues can serve as drug storage sites, competing with plasma binding sites for drug molecules.
Drugs can bind to different tissue components, enhancing their distribution and localization. The factors influencing drug localization in tissues include the drug's lipophilicity, structural characteristics, tissue perfusion rate, and pH differences. These factors determine...
455
Drug Distribution: Tissue Binding01:21

Drug Distribution: Tissue Binding

Upon entering the systemic circulation, drugs can distribute into the interstitial and intracellular fluid of various tissue cells. This distribution is facilitated by the binding of drugs to different cellular components within tissues, which may lead to drug accumulation in specific areas. Drugs bound to tissue components serve as reservoirs that release free drugs back into the system, prolonging the drug's overall action. However, this accumulation can also result in local toxicity.
For...
4.1K
Resistivity01:22

Resistivity

When a voltage is applied to a conductor, an electrical field is generated, and charges in the conductor feel the force due to the electrical field. The current density that results depends on the electrical field and the properties of the material. In some materials, including metals at a given temperature, the current density is approximately proportional to the electrical field. In these cases, the current density can be modeled as:
4.6K
Resistance01:19

Resistance

When a current moves through any conductor, the conductor causes some level of difficulty for the current to flow. The measure of that difficulty is known as the resistance of the material and is represented by R. Every material has its own resistance. In the case of conductors, heat is emitted whenever a current passes through them. Resistance depends on the resistivity of the material. Resistivity is a characteristic of the material used to fabricate electrical components, whereas the...
6.1K
Factors Affecting Drug Distribution: Tissue Permeability01:30

Factors Affecting Drug Distribution: Tissue Permeability

The drug distribution process within the human body is a complex interplay of various physicochemical properties inherent to the drugs. These properties, including molecular size, ionization degree, partition coefficient, and stereochemical nature, significantly impact how drugs permeate biological membranes to reach their target tissues.
Small molecules with a molecular weight below 500 to 600 Daltons can easily pass through the capillary membrane, gaining access to different tissues. Larger...
669